210 related articles for article (PubMed ID: 20713525)
1. Chromatin remodeling is required for gene reactivation after decitabine-mediated DNA hypomethylation.
Si J; Boumber YA; Shu J; Qin T; Ahmed S; He R; Jelinek J; Issa JP
Cancer Res; 2010 Sep; 70(17):6968-77. PubMed ID: 20713525
[TBL] [Abstract][Full Text] [Related]
2. Reassembly of nucleosomes at the MLH1 promoter initiates resilencing following decitabine exposure.
Hesson LB; Patil V; Sloane MA; Nunez AC; Liu J; Pimanda JE; Ward RL
PLoS Genet; 2013; 9(7):e1003636. PubMed ID: 23935509
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines.
Kawamoto K; Hirata H; Kikuno N; Tanaka Y; Nakagawa M; Dahiya R
Int J Cancer; 2008 Aug; 123(3):535-42. PubMed ID: 18404682
[TBL] [Abstract][Full Text] [Related]
4. Differential Histone Posttranslational Modifications Induced by DNA Hypomethylating Agents.
Malkaram SA; Shatnawi A; Fan J; Carraway H; Denvir J; Primerano DA; Abd Elmageed ZY; Fandy TE
Cancer Control; 2022; 29():10732748221074051. PubMed ID: 35067084
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation does not stably lock gene expression but instead serves as a molecular mark for gene silencing memory.
Raynal NJ; Si J; Taby RF; Gharibyan V; Ahmed S; Jelinek J; Estécio MR; Issa JP
Cancer Res; 2012 Mar; 72(5):1170-81. PubMed ID: 22219169
[TBL] [Abstract][Full Text] [Related]
6. Long term transcriptional reactivation of epigenetically silenced genes in colorectal cancer cells requires DNA hypomethylation and histone acetylation.
Mossman D; Scott RJ
PLoS One; 2011; 6(8):e23127. PubMed ID: 21829702
[TBL] [Abstract][Full Text] [Related]
7. Low dose decitabine treatment induces CD80 expression in cancer cells and stimulates tumor specific cytotoxic T lymphocyte responses.
Wang LX; Mei ZY; Zhou JH; Yao YS; Li YH; Xu YH; Li JX; Gao XN; Zhou MH; Jiang MM; Gao L; Ding Y; Lu XC; Shi JL; Luo XF; Wang J; Wang LL; Qu C; Bai XF; Yu L
PLoS One; 2013; 8(5):e62924. PubMed ID: 23671644
[TBL] [Abstract][Full Text] [Related]
8. Five-aza-2'-deoxycytidine-induced hypomethylation of cholesterol 25-hydroxylase gene is responsible for cell death of myelodysplasia/leukemia cells.
Tsujioka T; Yokoi A; Itano Y; Takahashi K; Ouchida M; Okamoto S; Kondo T; Suemori S; Tohyama Y; Tohyama K
Sci Rep; 2015 Nov; 5():16709. PubMed ID: 26577244
[TBL] [Abstract][Full Text] [Related]
9. Gene reactivation by 5-aza-2'-deoxycytidine-induced demethylation requires SRCAP-mediated H2A.Z insertion to establish nucleosome depleted regions.
Yang X; Noushmehr H; Han H; Andreu-Vieyra C; Liang G; Jones PA
PLoS Genet; 2012; 8(3):e1002604. PubMed ID: 22479200
[TBL] [Abstract][Full Text] [Related]
10. Effect of cytarabine and decitabine in combination in human leukemic cell lines.
Qin T; Youssef EM; Jelinek J; Chen R; Yang AS; Garcia-Manero G; Issa JP
Clin Cancer Res; 2007 Jul; 13(14):4225-32. PubMed ID: 17634552
[TBL] [Abstract][Full Text] [Related]
11. A comparison of azacitidine and decitabine activities in acute myeloid leukemia cell lines.
Hollenbach PW; Nguyen AN; Brady H; Williams M; Ning Y; Richard N; Krushel L; Aukerman SL; Heise C; MacBeth KJ
PLoS One; 2010 Feb; 5(2):e9001. PubMed ID: 20126405
[TBL] [Abstract][Full Text] [Related]
12. Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter.
Plumb JA; Strathdee G; Sludden J; Kaye SB; Brown R
Cancer Res; 2000 Nov; 60(21):6039-44. PubMed ID: 11085525
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic synergy between decitabine and platinum derivatives.
Qin T; Si J; Raynal NJ; Wang X; Gharibyan V; Ahmed S; Hu X; Jin C; Lu Y; Shu J; Estecio MR; Jelinek J; Issa JJ
Clin Epigenetics; 2015; 7(1):97. PubMed ID: 26366234
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation and gene silencing in cancer.
Baylin SB
Nat Clin Pract Oncol; 2005 Dec; 2 Suppl 1():S4-11. PubMed ID: 16341240
[TBL] [Abstract][Full Text] [Related]
15. Decitabine-Induced Changes in Human Myelodysplastic Syndrome Cell Line SKM-1 Are Mediated by FOXO3A Activation.
Zeng W; Dai H; Yan M; Cai X; Luo H; Ke M; Liu Z
J Immunol Res; 2017; 2017():4302320. PubMed ID: 29124072
[TBL] [Abstract][Full Text] [Related]
16. Genomic impact of transient low-dose decitabine treatment on primary AML cells.
Klco JM; Spencer DH; Lamprecht TL; Sarkaria SM; Wylie T; Magrini V; Hundal J; Walker J; Varghese N; Erdmann-Gilmore P; Lichti CF; Meyer MR; Townsend RR; Wilson RK; Mardis ER; Ley TJ
Blood; 2013 Feb; 121(9):1633-43. PubMed ID: 23297133
[TBL] [Abstract][Full Text] [Related]
17. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
Magdinier F; Wolffe AP
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4990-5. PubMed ID: 11309512
[TBL] [Abstract][Full Text] [Related]
18. Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions.
Kopp LM; Ray A; Denman CJ; Senyukov VS; Somanchi SS; Zhu S; Lee DA
Mol Immunol; 2013 Jul; 54(3-4):296-301. PubMed ID: 23328088
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of human cancer cells by 5-aza-2'-deoxycytidine does not correlate with its effects on INK4a/ARF expression or initial promoter methylation status.
Xiong J; Epstein RJ
Mol Cancer Ther; 2009 Apr; 8(4):779-85. PubMed ID: 19372550
[TBL] [Abstract][Full Text] [Related]
20. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2'-deoxycytidine.
Nguyen CT; Weisenberger DJ; Velicescu M; Gonzales FA; Lin JC; Liang G; Jones PA
Cancer Res; 2002 Nov; 62(22):6456-61. PubMed ID: 12438235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]